Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 29.99 M31.73 M 121.98 M Research & development —— — Operating income 23.79 M12.42 M 89.2 M Non-Operating Income, Total -1.49 M-1.32 M -6.22 M Interest expense, net of interest capitalized 523 K419 K 2.43 M Non-Operating Income, excl. Interest Expenses -2.01 M-1.74 M -8.65 M Unusual income/expense —— — Pretax income 22.3 M11.1 M 82.97 M Equity in earnings —— — Taxes 5.45 M2.7 M 21.04 M Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 16.85 M8.4 M 61.93 M Discontinued operations —— — Net income 16.85 M8.4 M 61.93 M Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 16.85 M8.4 M 61.93 M Basic earnings per share (Basic EPS) 1.440.71 5.29 Diluted earnings per share (Diluted EPS) 1.430.71 5.26 Average basic shares outstanding 11.72 M11.7 M — Diluted shares outstanding 11.8 M11.78 M — EBITDA 30.82 M19.41 M 117.4 M EBIT 23.79 M12.42 M 89.2 M Cost of revenue 228.01 M236.29 M 964.49 M Other cost of goods sold —— — Depreciation & amortization (cash flow) 7.04 M6.98 M 28.2 M